Since the early 1990s, extracorporeal shockwaves have also been used successfully to treat chronic pain conditions.
Extracorporeal shockwave therapy (ESWT) and trigger point shockwave therapy (TPST) treat chronic pain of the musculoskeletal system efficiently and non-invasively. ESWT has been used successfully for a growing number of indications in the treatment of acute and chronic musculoskeletal pain and has thus earned a firm place in conservative medical treatment.
Mechanisms of action and effects of ESWT described in the literature:
- Induction of the release of growth factors such as TGF-ß1 and VEGF
- Stimulation of fibroblast proliferation
- Stimulation of mesenchymal stem cell migration
- Promotes local blood circulation and inhibits pro-inflammatory processes
For more information, visit www.elvation.de
Extracorporeal shockwaves
Typical orthopedic indications for shockwave therapy (ESWT) are disorders at tendon insertions, such as soft-tissue changes of the rotator cuff in the shoulder, tennis or golfer's elbow, patellar tip syndrome in the knee, or plantar fasciitis with heel pain.
In sports medicine, insertional tendinopathy (enthesopathy) is one of the standard indications for focused shockwave therapy.
When clinical studies evaluate the effect of ESWT in this field, the focus is on stimulating or activating tissue substances that play a key role in self-healing, rather than on tissue destruction.
Trigger point shockwave therapy
With trigger point shockwave therapy (TPST), the penetration depth, intensity, power and pulse frequency of the shockwave pulses can easily be adapted to each indication.
Before treatment, trigger points can be located precisely with a precisely defined focus. Thanks to the variable penetration depth, even trigger points deep in the muscle tissue can be located and treated precisely. This greatly increases treatment efficiency.
The FP4 planar therapy source of the PiezoWave device significantly extends the treatment range of ESWT/TPST, so large myofascial syndromes close to the skin surface can be treated successfully. Combining the FP4 planar therapy source with the F10 G4 focused therapy source also makes it possible to treat many orthopedic indications.